RxDoctor Payments Data

Hallie Clark, NP

Nurse Practitioner · Oakland City, INNPI 1326638537

Payments from drug & device makers

$313in general payments, 2019–2025

Across 19 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$84
  • Novo Nordisk$34
  • Nestle Healthcare Nutrition Inc.$31
  • Amgen$26
  • Biohaven Pharmaceuticals, Inc.$20
  • Axsome Therapeutics, Inc.$19
  • plus $100 from 7 others

What the payments were for

  • Food & beverage$313100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$313 in reported general payments places this provider in the 55th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$2,065
Medicare patients
29
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$35,484
JardianceEmpagliflozin14$12,572
FarxigaDapagliflozin Propanediol15$9,493
EliquisApixaban15$8,732
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,755
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,446
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$1,190
Duloxetine Hcl27$683
Buspirone Hcl32$660
Clonazepam27$569
Albuterol Sulfate HfaAlbuterol Sulfate27$424
Doxycycline Monohydrate32$386
Gabapentin13$362
Omeprazole29$346
Fluticasone Propionate28$231

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$35,48432 claims
AstraZenecaFarxiga$13$9,49315 claims
GSKTrelegy Ellipta$13$7,75512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Oakland City

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →